DiaSorin Financial Statements From 2010 to 2024
| DSRLF Stock | USD 106.85 0.32 0.30% |
Check DiaSorin SpA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DiaSorin SpA's main balance sheet or income statement drivers, such as , as well as many indicators such as . DiaSorin financial statements analysis is a perfect complement when working with DiaSorin SpA Valuation or Volatility modules.
DiaSorin |
DiaSorin SpA Company Operating Margin Analysis
DiaSorin SpA's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current DiaSorin SpA Operating Margin | 0.29 % |
Most of DiaSorin SpA's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DiaSorin SpA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, DiaSorin SpA has an Operating Margin of 0.2942%. This is 100.84% lower than that of the Healthcare sector and 100.46% lower than that of the Diagnostics & Research industry. The operating margin for all United States stocks is 105.34% lower than that of the firm.
DiaSorin SpA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DiaSorin SpA's current stock value. Our valuation model uses many indicators to compare DiaSorin SpA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DiaSorin SpA competition to find correlations between indicators driving DiaSorin SpA's intrinsic value. More Info.DiaSorin SpA is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DiaSorin SpA is roughly 2.20 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DiaSorin SpA's earnings, one of the primary drivers of an investment's value.About DiaSorin SpA Financial Statements
DiaSorin SpA stakeholders use historical fundamental indicators, such as DiaSorin SpA's revenue or net income, to determine how well the company is positioned to perform in the future. Although DiaSorin SpA investors may analyze each financial statement separately, they are all interrelated. For example, changes in DiaSorin SpA's assets and liabilities are reflected in the revenues and expenses on DiaSorin SpA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DiaSorin SpA. Please read more on our technical analysis and fundamental analysis pages.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN SPA operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 3350 people.
Currently Active Assets on Macroaxis
Other Information on Investing in DiaSorin Pink Sheet
DiaSorin SpA financial ratios help investors to determine whether DiaSorin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.